Ignaty Leschiner

发表

TAS-120 overcomes resistance to ATP-competitive FGFR inhibitors in patients with FGFR2 fusion-positive intrahepatic cholangiocarcinoma.

W. Hahn, G. Getz, A. Iafrate, 2019, Cancer discovery.